According to Galectin Therapeutics's latest financial reports the company's current earnings (TTM) are -NZ$71.59 M. In 2023 the company made an earning of -NZ$66.38 M a decrease over its 2022 earnings that were of -NZ$62.68 M.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.